< Key Hightlight >

MARKET OUTLOOK

Triton Market Research’s report infers that the Asia-Pacific cosmetic surgery and procedures market is predicted to surge at 6.56% of CAGR during 2021-2028. China, Australia & New Zealand, Japan, South Korea, ASEAN countries, India, and Rest of APAC form the market across the region.

In India, the popularity of cosmetic procedures has increased significantly due to the rise in obesity, surge in the aging populations, and increase in the influence of western culture. Additionally, owing to the country’s tropical climate, there is a rise in demand for anti aging treatment. Further, cosmetic procedures have witnessed a radical change over the past few years, mainly owing to the growing affordability and adoption of newer technologies. Earlier, cosmetic surgeries were for patients suffering from major skin burns and other conditions. However, nowadays, people are opting for these procedures to enhance aesthetic appeal. This rise in cosmetic procedures drives the growth of the cosmetic surgery and procedures market. 

South Korea is considered the capital of cosmetic surgeries in the region. Moreover, it is expected to maintain dominance over the next few years. Over the years, a surge in demand for beautification, expenditure on aesthetic enhancement, and availability of advanced procedures are supporting the demand for these procedures across the country. Several consumers are opting for eyelid surgery, which involves the insertion of an extra fold in the eyelids. This is gaining momentum among the younger populations. Rhinoplasty is another procedure gaining traction across the country, thereby augmenting the growth of the South Korean cosmetic surgery and procedures market.

COMPETITIVE OUTLOOK

The leading firms in the cosmetic surgery and procedures market include Merz Pharma, Johnson and Johnson, Candela Corporation, Ipsen Group, Cutera Inc, and Sinclair Pharma.